Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-24 10:00 PM View:  | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 05-Mar-24 | Sale (Planned) | 3,300 | $7.00 | $23,101.00 | (1%) 248.65K to 245.35K | |
| 27-Feb-24 7:29 PM View: | Patterson Leone D Chief Fin. and Bus. Officer | Tenaya Therapeutics, Inc. (TNYA) | 23-Feb-24 | Grant | 35,000 | -- | -- | 58% 60.76K to 95.75K | |
| 27-Feb-24 7:28 PM View: | Ali Faraz Chief Executive Officer Director | Tenaya Therapeutics, Inc. (TNYA) | 23-Feb-24 | Grant | 85,000 | -- | -- | 75% 113.08K to 198.08K | |
| 27-Feb-24 7:31 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 23-Feb-24 | Grant | 12,500 | -- | -- | 5% 236.15K to 248.65K | |
| 27-Feb-24 7:30 PM View: | Tingley Whittemore Chief Medical Officer | Tenaya Therapeutics, Inc. (TNYA) | 23-Feb-24 | Grant | 35,000 | -- | -- | 48% 73.53K to 108.53K | |
| 21-Feb-24 6:05 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 20-Feb-24 | Sale (Planned) | 6,569 | $5.34 | $35,046.00 | (3%) 242.72K to 236.15K | |
| 16-Feb-24 8:30 PM View: | Ali Faraz Chief Executive Officer Director | Tenaya Therapeutics, Inc. (TNYA) | 16-Feb-24 | Sale | 6,358 | $5.86 | $37,257.90 | (5%) 119.44K to 113.08K | |
| 16-Feb-24 8:37 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 16-Feb-24 | Sale | 4,681 | $5.86 | $27,430.70 | (2%) 247.4K to 242.72K | |
| 16-Feb-24 8:35 PM View: | Tingley Whittemore Chief Medical Officer | Tenaya Therapeutics, Inc. (TNYA) | 16-Feb-24 | Sale | 6,500 | $5.86 | $38,090.00 | (8%) 80.03K to 73.53K | |
| 16-Feb-24 8:32 PM View: | Patterson Leone D Chief Fin. and Bus. Officer | Tenaya Therapeutics, Inc. (TNYA) | 16-Feb-24 | Sale | 5,201 | $5.86 | $30,477.90 | (8%) 65.96K to 60.76K | |
| 14-Feb-24 4:15 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 12-Feb-24 | Private Purchase Duplicate | 2,222,220 | $4.50 | $10,000,000.00 | 11% 20.78M to 23.0M | |
| 14-Feb-24 4:12 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 12-Feb-24 | Private Purchase | 2,222,220 | $4.50 | $10,000,000.00 | 11% 20.78M to 23.0M | |
| 29-Aug-23 6:59 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 29-Aug-23 | Sale (Planned) | 7,243 | $4.26 | $30,855.20 | (3%) 254.64K to 247.4K | |
| 18-Aug-23 6:31 PM View: | Patterson Leone D Chief Fin. and Bus. Officer | Tenaya Therapeutics, Inc. (TNYA) | 16-Aug-23 | Sale | 4,452 | $3.81 | $16,962.10 | (6%) 68.99K to 64.54K | |
| 18-Aug-23 6:34 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 16-Aug-23 | Sale | 4,007 | $3.81 | $15,266.70 | (2%) 258.65K to 254.64K | |
| 18-Aug-23 6:31 PM View: | Ali Faraz Chief Executive Officer Director | Tenaya Therapeutics, Inc. (TNYA) | 16-Aug-23 | Sale | 5,563 | $3.81 | $21,195.00 | (4%) 125.0K to 119.44K | |
| 18-Aug-23 6:33 PM View: | Tingley Whittemore Chief Medical Officer | Tenaya Therapeutics, Inc. (TNYA) | 16-Aug-23 | Sale | 5,563 | $3.81 | $21,195.00 | (7%) 82.0K to 76.44K | |
| 14-Mar-23 4:12 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 10-Mar-23 | Private Purchase Duplicate | 6,779 | $2.60 | $17,595.60 | < 1% 20.77M to 20.78M | |
| 14-Mar-23 4:09 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 10-Mar-23 | Private Purchase | 6,779 | $2.60 | $17,595.60 | < 1% 20.77M to 20.78M | |
| 17-Feb-23 6:43 PM View: | Ali Faraz Chief Executive Officer Director | Tenaya Therapeutics, Inc. (TNYA) | 15-Feb-23 | Grant | 125,000 | -- | -- | 100% 0 to 125.0K | |
| 17-Feb-23 6:47 PM View: | Tingley Whittemore Chief Medical Officer | Tenaya Therapeutics, Inc. (TNYA) | 15-Feb-23 | Grant | 80,000 | -- | -- | 100% 0 to 80.0K | |
| 17-Feb-23 6:45 PM View: | Patterson Leone D Chief Fin. and Bus. Officer | Tenaya Therapeutics, Inc. (TNYA) | 15-Feb-23 | Grant | 65,000 | -- | -- | 3250% 2.0K to 67.0K | |
| 17-Feb-23 6:48 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 15-Feb-23 | Grant | 60,000 | -- | -- | 30% 198.65K to 258.65K | |
| 10-Feb-23 4:22 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 08-Feb-23 | Private Purchase | 1,500,000 | $2.60 | $3,900,000.00 | 8% 19.27M to 20.77M | |
| 10-Feb-23 4:32 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 08-Feb-23 | Private Purchase Duplicate | 1,500,000 | $2.60 | $3,900,000.00 | 8% 19.27M to 20.77M | |
| 23-Jan-23 4:25 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 19-Jan-23 | Private Purchase Duplicate | 69,739 | $2.50 | $174,201.00 | < 1% 19.2M to 19.27M | |
| 23-Jan-23 4:21 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 19-Jan-23 | Private Purchase | 69,739 | $2.50 | $174,201.00 | < 1% 19.2M to 19.27M | |
| 19-Jan-23 4:18 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 18-Jan-23 | Purchase Duplicate | 135,688 | $2.52 | $341,432.00 | < 1% 19.07M to 19.2M | |
| 19-Jan-23 4:13 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 18-Jan-23 | Purchase | 135,688 | $2.52 | $341,432.00 | < 1% 19.07M to 19.2M | |
| 19-Jan-23 4:13 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 17-Jan-23 | Private Purchase | 49,463 | $2.49 | $123,395.00 | < 1% 19.02M to 19.07M | |
| 19-Jan-23 4:18 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 17-Jan-23 | Private Purchase Duplicate | 49,463 | $2.49 | $123,395.00 | < 1% 19.02M to 19.07M | |
| 23-Nov-22 4:12 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 21-Nov-22 | Private Purchase Duplicate | 9,615,380 | $2.60 | $25,000,000.00 | 102% 9.4M to 19.02M | |
| 23-Nov-22 4:11 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 21-Nov-22 | Private Purchase | 9,615,380 | $2.60 | $25,000,000.00 | 102% 9.4M to 19.02M | |
| 09-Dec-22 7:59 PM View: | Srivastava Deepak Director | Tenaya Therapeutics, Inc. (TNYA) | 21-Nov-22 | Private Purchase | 230,769 | $2.60 | $599,999.00 | 69% 333.33K to 564.1K | |
| 25-Nov-22 7:05 PM View: | Casdin Eli Director | Tenaya Therapeutics, Inc. (TNYA) | 17-Nov-22 | Private Purchase | 2,492,040 | $2.60 | $6,479,310.00 | 69% 3.59M to 6.08M | |
| 28-Apr-22 7:57 PM View: | Hoey Timothy Chief Scientific Officer | Tenaya Therapeutics, Inc. (TNYA) | 26-Apr-22 | Sale (Planned) | 1,353 | $10.13 | $13,705.90 | (< 1%) 200.0K to 198.65K | |
| 04-Aug-21 6:33 PM View: | Casdin Partners Master Fund... 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Purchase | 850,000 | $15.00 | $12,750,000.00 | 31% 2.74M to 3.59M | |
| 04-Aug-21 6:34 PM View: | Column Group III Gp, Lp 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Conversion Duplicate | 9,346,120 | -- | -- | 17255% 54.17K to 9.4M | |
| 04-Aug-21 6:32 PM View: | Casdin Eli Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Purchase Duplicate | 850,000 | $15.00 | $12,750,000.00 | 31% 2.74M to 3.59M | |
| 04-Aug-21 6:30 PM View: | Kang Jeenjoo Director | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Conversion | 12,500 | -- | -- | 100% 12.5K to 25.0K | |
| 04-Aug-21 6:31 PM View: | Goeddel David V Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Conversion | 9,346,120 | -- | -- | 17255% 54.17K to 9.4M | |
| 04-Aug-21 6:33 PM View: | Casdin Partners Master Fund... 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Conversion | 2,736,820 | -- | -- | 100% 0 to 2.74M | |
| 04-Aug-21 6:32 PM View: | Casdin Eli Director 10% Owner | Tenaya Therapeutics, Inc. (TNYA) | 03-Aug-21 | Conversion Duplicate | 2,736,820 | -- | -- | 100% 0 to 2.74M |
